Story preview
CEO buys 20,800 shares and receives 255,174 stock options at Retension Pharmaceuticals (RTSN).
About this story
- Published
- Oct 14, 2026, 12:14 AM UTC
Continue reading on the publisher site for the full article.
Read on publisher →Stock Titan
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee